← Back to Clinical Trials
Recruiting NCT06275113

NCT06275113 BRING-UP Prevention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06275113
Status Recruiting
Phase
Sponsor Heart Care Foundation
Condition Ischemic Heart Disease
Study Type OBSERVATIONAL
Enrollment 6,000 participants
Start Date 2023-09-15
Primary Completion 2026-06-30

Trial Parameters

Condition Ischemic Heart Disease
Sponsor Heart Care Foundation
Study Type OBSERVATIONAL
Phase N/A
Enrollment 6,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-09-15
Completion 2026-06-30

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of this observational study is to assess in patients with a documented athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral artery disease (PAD): * the level of adherence to guideline recommendations with the assumption to improve the rate of patients at goal for cholesterol levels. * the level of adherence to guideline recommendations and the rate of patients at goal for the other relevant and modifiable risk factors for cardiovascular event recurrence.

Eligibility Criteria

Inclusion Criteria: * Both sexes at birth, age ≥18 years At least one of the following clinical conditions: * Documented CAD defined as: * Prior Acute Coronary Syndrom (ACS) * Prior Coronary Artery Bypass Graft (CABG) * Prior Percutaneous Coronary Intervention (PCI) * Documented PAD (previous peripheral bypass surgery or angioplasty, limb or foot amputation, intermittent claudication with objective evidence of peripheral artery disease, Ankle Brachial Index (ABI)\<90). * Documented CVD: Ischemic stroke, previous carotid vascular interventions. * Signed informed consent. Exclusion Criteria: * Active neoplasia or very severe disease compromising short-medium term life expectancy. * Participation in interventional studies. * Patients already enrolled into the study from another participating center or in the previous enrolling phase.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology